Protein Intake Associated With Physical Activity Related to Specific Outcomes
NCT ID: NCT03438201
Last Updated: 2018-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
126 participants
INTERVENTIONAL
2018-04-04
2020-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Protein Intake and Early Exercise in Adult Intensive Care Patients
NCT03469882
Higher Protein Diet and Exercise for Optimal Weight Loss in Elderly Women
NCT00912210
Relationship Between Protein Intake and ICU Skeletal Muscle Weakness
NCT06012201
Optimized Caloric-proteic Nutrition in Critically Ill Patients
NCT03060668
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
NCT06858449
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The proposed intervention is a post operative diet with a different amount of protein (diet with a standard amount of protein and a diet with high amount of protein) associated to an institutional protocol of physical activity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-protein diet
High Protein Diet (2,0 - 2,5g/Kg body weight/day) Physical Activity protocol
Intervention
Enteral feeding that will give the patient the amount of protein between 2.0 - 2.5 Kg/body weight/Day
Normoproteic diet
Standard Protein Diet (1,0 - 1,2g/Kg body weight/day) Physical Activity protocol
Control
Enteral feeding that will give the patient the amount of protein between 1.0 - 1.2 Kg/body weight/Day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
Enteral feeding that will give the patient the amount of protein between 2.0 - 2.5 Kg/body weight/Day
Control
Enteral feeding that will give the patient the amount of protein between 1.0 - 1.2 Kg/body weight/Day
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age greater than or equal to 18 years old
* Have a tendency to be admitted to the ICU after the surgery
* Fill the eligible criteria to start enteral feeding within 72 hours
* Sign the consent form;
Exclusion Criteria
* Bronchopleural fistula
* Karnofsky \<50
* Participant cannot b enrolled in another study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Juliano P Almeida, MD, PhD
Medical Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juliano P Almeida, Professor
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo
Ilana Roitman
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine University of Sao Paulo
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
77623917.0.0000.0065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.